LNCAROD and hepatocellular carcinoma: LINC01468 silencing reduced the proliferative capacity of HCC cells (Fig. 2A, all P < 0.01), and LINC01468 knockdown inhibited the migration and invasion of HCC cells (Fig. 2B, all P < 0.05).